177 related articles for article (PubMed ID: 34572265)
21. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.
Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771
[TBL] [Abstract][Full Text] [Related]
22. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
23. MiR-30c-5p mediates the effects of panax notoginseng saponins in myocardial ischemia reperfusion injury by inhibiting oxidative stress-induced cell damage.
Wang L; Chen X; Wang Y; Zhao L; Zhao X; Wang Y
Biomed Pharmacother; 2020 May; 125():109963. PubMed ID: 32036220
[TBL] [Abstract][Full Text] [Related]
24. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
25. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
26. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in Oral Squamous Cell Carcinoma: A Potential Biomarkers Panel?
Aghiorghiesei O; Zanoaga O; Raduly L; Aghiorghiesei AI; Chiroi P; Trif A; Buiga R; Budisan L; Lucaciu O; Pop LA; Braicu C; Campian R; Berindan-Neagoe I
Curr Issues Mol Biol; 2022 Apr; 44(4):1754-1767. PubMed ID: 35723379
[TBL] [Abstract][Full Text] [Related]
28. Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis.
Nakamura K; Hiyake N; Hamada T; Yokoyama S; Mori K; Yamashiro K; Beppu M; Sagara Y; Sagara Y; Sugiura T
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33504017
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
[TBL] [Abstract][Full Text] [Related]
30. A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma.
Patel A; Patel P; Mandlik D; Patel K; Malaviya P; Johar K; Swamy KBS; Patel S; Tanavde V
Biomark Res; 2023 Jun; 11(1):64. PubMed ID: 37316916
[TBL] [Abstract][Full Text] [Related]
31. miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers.
Chamorro Petronacci CM; Pérez-Sayáns M; Padín Iruegas ME; Suárez Peñaranda JM; Lorenzo Pouso AI; Blanco Carrión A; García García A
Medicine (Baltimore); 2019 Mar; 98(13):e14922. PubMed ID: 30921188
[TBL] [Abstract][Full Text] [Related]
32. KCNQ1OT1 promotes migration and inhibits apoptosis by modulating miR-185-5p/Rab14 axis in oral squamous cell carcinoma.
Bao Q; Liao X; Li R; Ding N
Dev Growth Differ; 2019 Dec; 61(9):466-474. PubMed ID: 31755091
[TBL] [Abstract][Full Text] [Related]
33. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
Wang X; Li F; Zhou X
Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
[TBL] [Abstract][Full Text] [Related]
34. A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer.
Chang YA; Weng SL; Yang SF; Chou CH; Huang WC; Tu SJ; Chang TH; Huang CN; Jong YJ; Huang HD
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518940
[TBL] [Abstract][Full Text] [Related]
35. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
[TBL] [Abstract][Full Text] [Related]
36. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
37. Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma.
Huang G; Li H; Wang J; Peng X; Liu K; Zhao L; Zhang C; Chen X; Lai Y; Ni L
Pathol Res Pract; 2020 Nov; 216(11):153152. PubMed ID: 32823234
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.
Ostadrahimi S; Fayaz S; Parvizhamidi M; Abedi-Valugerdi M; Hassan M; Kadivar M; Teimoori-Toolabi L; Asgari M; Shahrokh H; Abolhasani M; Mahdian R; Fard-Esfahani P
Oncol Lett; 2018 May; 15(5):8157-8164. PubMed ID: 29849810
[TBL] [Abstract][Full Text] [Related]
39. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
[TBL] [Abstract][Full Text] [Related]
40. The RNA-binding protein hnRNPU regulates the sorting of microRNA-30c-5p into large extracellular vesicles.
Zietzer A; Hosen MR; Wang H; Goody PR; Sylvester M; Latz E; Nickenig G; Werner N; Jansen F
J Extracell Vesicles; 2020 Jul; 9(1):1786967. PubMed ID: 32944175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
